InMode raises full-year revenue guidance to a range of $530 mln to $540 mln vs. $525 mln to $530 mln previously.

Average Recommendation, Overweight. Average Target Price, 21.33. Number Of Ratings, 7. FY Report Date, 12/2024. Last Quarter's Earnings, 0.70.

InMode Ltd. · Industry Medical Equipment/Supplies · Sector Health Care/Life Sciences · Fiscal Year-end 12/2024 · Revenue $492.05M · Net Income $197.92M · 2023 ...

InMode Ltd. advanced stock charts by MarketWatch. View INMD historial stock data and compare to other stocks and exchanges.

InMode Ltd. options data by MarketWatch. View INMD option chain data and pricing information for given maturity periods.

InMode Ltd. Annual stock financials by MarketWatch. View the latest INMD financial statements, income statements and financial ratios.

Download InMode Ltd. stock data: historical INMD stock prices from MarketWatch.

InMode Ltd. company facts, information and financial ratios from MarketWatch.

InMode Ltd. SEC filings breakout by MarketWatch. View the INMD U.S. Securities and Exchange Commission reporting information.

News for InMode Ltd. Wednesday, December 06, 2023. 07:52 AM ET. InMode's stock slides 13% after Israeli medtech company issues profit warning MarketWatch.